Strensall, York CMTA Community Event

07/23/2025 @ 9:00 am – 12:00 pm – You are warmly invited to CMTea! A friendly community get-together hosted by Dr. Katherine Forsey, CMTA’s Chief Research Officer. This community event will be held on Wednesday, 23rd July 2025 from 9am-12pm BST.  The event is located at Spearehead Hall Community Cafe, St Mary’s Church Hall, Strensall, York. YO32 5XU. UK. This is an accessible […]

The Fall 2020 CMTA Report

…issue is available now and full of information for you. Inside, we bring you coverage of CMT research projects with a special focus on CMT1A, stories and perspectives from people…

CMTA and Addex Announce CMT1A Collaboration

…of key outcomes. These outcome measures include biomarkers, motor function, electrophysiology and peripheral nerve histology. This is made possible through the CMTA’s preclinical testing alliance: www.cmtausa.org/our-research/for-researchers/cmta-preclinical-testing-network/ Download the full release…

Hereditary Sensory Neuropathy (HSN)

…the DNMT1 gene. HSN1F HSN1F is due to the gene ATL3 on chromosome 11q12.3-q13.1. HSN Research Hereditary Sensory Neuropathy Serine trial (SENSE trial) See what’s happening in HSN research ⟶…

Donate to CMTA

…(Strategy To Accelerate Research), we are accelerating groundbreaking discoveries to develop treatments and, ultimately, a cure for all types of CMT. Your donation directly fuels innovative research that addresses every…

The 2021 CMTA Annual Report

…our community outreach efforts invigorate and inform our research efforts, with the community providing the energy, excitement and funding for the research. You’ll read about all of it in the…

CMTA Announces New Center of Excellence in Cincinnati

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Hani Kushlaf, MD, FAAN, FANA, FAANEM, at the University…

CMTA Announces Its First Center of Excellence in Scotland

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Katie Brennan, MD, PhD, at Queen Elizabeth University Hospital…